Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.

Malkin E, Zaric M, Kieh M, Baden LR, Fitz-Patrick D, Marini A, Yun H, Hayes P, Bromell R, Ayorinde M, Fernandez N, Varma R, Sigei F, Ward M, Pindolia H, Sewell S, Amini F, Blie J, Wilson B, Faley P, McCullough J, Tokpah F, Wisseh C, Towalid E, Hadawale S, Sayeed E, Hunt D, Keshavarzi N, Barin B, Maljkovic Berry I, Parks CL, Truter SG, Walker K, Vekemans J, Lehrman J, Engelbrecht M, Malherbe M, Laufer D, Philiponis V, Higgs E, Mutua G, Fast PE, Gupta SB, rVSVΔG-LASV-GPC Study Group

Open source

DOI: 10.1056/nejmoa2501073
Published: 2025 Nov 6
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2501073,
  title = {Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.},
  author = {Malkin E and Zaric M and Kieh M and Baden LR and Fitz-Patrick D and Marini A and Yun H and Hayes P and Bromell R and Ayorinde M and Fernandez N and Varma R and Sigei F and Ward M and Pindolia H and Sewell S and Amini F and Blie J and Wilson B and Faley P and McCullough J and Tokpah F and Wisseh C and Towalid E and Hadawale S and Sayeed E and Hunt D and Keshavarzi N and Barin B and Maljkovic Berry I and Parks CL and Truter SG and Walker K and Vekemans J and Lehrman J and Engelbrecht M and Malherbe M and Laufer D and Philiponis V and Higgs E and Mutua G and Fast PE and Gupta SB and rVSVΔG-LASV-GPC Study Group},
  year = {2025},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2501073},
  url = {https://doi.org/10.1056/nejmoa2501073}
}

RIS

TY  - JOUR
TI  - Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.
AU  - Malkin E
AU  - Zaric M
AU  - Kieh M
AU  - Baden LR
AU  - Fitz-Patrick D
AU  - Marini A
AU  - Yun H
AU  - Hayes P
AU  - Bromell R
AU  - Ayorinde M
AU  - Fernandez N
AU  - Varma R
AU  - Sigei F
AU  - Ward M
AU  - Pindolia H
AU  - Sewell S
AU  - Amini F
AU  - Blie J
AU  - Wilson B
AU  - Faley P
AU  - McCullough J
AU  - Tokpah F
AU  - Wisseh C
AU  - Towalid E
AU  - Hadawale S
AU  - Sayeed E
AU  - Hunt D
AU  - Keshavarzi N
AU  - Barin B
AU  - Maljkovic Berry I
AU  - Parks CL
AU  - Truter SG
AU  - Walker K
AU  - Vekemans J
AU  - Lehrman J
AU  - Engelbrecht M
AU  - Malherbe M
AU  - Laufer D
AU  - Philiponis V
AU  - Higgs E
AU  - Mutua G
AU  - Fast PE
AU  - Gupta SB
AU  - rVSVΔG-LASV-GPC Study Group
PY  - 2025
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2501073
UR  - https://doi.org/10.1056/nejmoa2501073
ER  -

APA

E, M., M, Z., M, K., LR, B., D, F., A, M., H, Y., P, H., R, B., M, A., N, F., R, V., F, S., M, W., H, P., S, S., F, A., J, B., B, W., P, F., J, M., F, T., C, W., E, T., S, H., E, S., D, H., N, K., B, B., I, M. B., CL, P., SG, T., K, W., J, V., J, L., M, E., M, M., D, L., V, P., E, H., G, M., PE, F., SB, G., & Group, R. S. (2025). Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2501073

Source records

pubmed · retrieved 2026-09-26T04:56:02.743Z